Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 16, 2009Journal of Clinical InvestigationOpen Access

Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells

View Full Paper
Ask AI
Bookmark
Share

Authors

ZZZhihui ZhongSun Yat-sen UniversityHIHristelina IlievaThomas Jefferson UniversityLHLee D. HallaganMaine Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhong et al. (2009) studied this question.

synapsesocial.com/papers/6a9989b694826fd4daa5f2d9https://doi.org/10.1172/jci38476
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice2009 · 178 citations
  2. 2The Endothelial Cell Protein C Receptor2000 · 218 citations
  3. 3Activated Protein C Promotes Neovascularization and Neurogenesis in Postischemic Brain via Protease-Activated Receptor 12008 · 103 citations
  4. 4IgG-Assisted Age-Dependent Clearance of Alzheimer's Amyloid β Peptide by the Blood–Brain Barrier Neonatal Fc Receptor2005 · 231 citations